Skip to content

FostrSpace-CASA R61/R33

CASA and FostrSpace: Systems Delivery of Digital Substance Use Prevention Tools to Foster Youth

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06875323
Enrollment
400
Registered
2025-03-13
Start date
2024-03-01
Completion date
2029-03-01
Last updated
2026-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Use

Keywords

Foster youth, Substance use, mHealth

Brief summary

The purpose of this study is to understand how an online digital health application (app) called FostrSpace can reduce substance use among youth (ages 13-20 years old) in foster care.

Detailed description

The goal of this clinical trial is to identify gaps in substance use prevention across existing CASA trainings and the FostrSpace app for foster youth and test how substance use trainings for CASA volunteers could help facilitate FostrSace app referrals to reduce and prevent substance use among CASA youth.

Interventions

OTHERECHO-FostrSpace

Six ECHO-FostrSpace session training for CASA volunteers.

OTHERInformational Session

One ECHO-FostrSpace session training for CASA volunteers.

Sponsors

University of California, San Francisco
Lead SponsorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to 20 Years
Healthy volunteers
Yes

Inclusion criteria

* Adolescents and young adults will be eligible if they are age 13-20, are proficient in English, have an assigned CASA worker, and have a device with web access. * CASAs (ages 18 and over) will be eligible if they are assigned to a youth between the ages of 13- 20.

Exclusion criteria

* Youth:

Design outcomes

Primary

MeasureTime frameDescription
Rate of Drug UsebaselineThe Texas Christian University (TCU) drug screen with opioid supplement is used to gather detailed information about drug and opioid use.
Rate of Cigarette UsebaselineThe Cigarette smoking and vaping/e-cigarette use is used to gather detailed information about nicotine and/or cannabis use.

Secondary

MeasureTime frameDescription
The Alcohol and Marijuana Expectancy QuestionnairebaselineThe Alcohol and Marijuana Expectancy questionnaire is used to measure positive and negative expectancies about affective, cognitive and behavioral effects of alcohol and cannabis use. Items are rated from 1-5 scale and higher scores indicate negative alcohol and marijuana expectancies.
The Brief Young Adult Alcohol Consequences QuestionnairebaselineThe Brief Young Adult Alcohol Consequences Questionnaire is used to assess the severity of alcohol consumption. Higher scores indicate greater severity of consequences associated with alcohol consumption.
The Brief Marijuana Consequences QuestionnairebaselineThe Brief Marijuana Consequences Questionnaire is used to assess the severity of marijuana consumption. Higher scores indicate greater severity of consequences associated with marijuana consumption.
The Brief Symptom InventorybaselineBrief Symptom Inventory is used to measure depression, anxiety and somatization symptoms to assess for psychiatry distress. Index ranging from 0 to 72 with cut-score of 11 as indication of psychiatric distress.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMarina Tolou-Shams, PhD

University of California, San Francisco

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 30, 2026